Immunohistology and immunohistochemstry study of ovarian cancer
- VernacularTitle:Өндгөвчийн хортой хавдрын иммунгистологи-дархангистохимийн судалгаа
- Author:
Odonzul Ts
1
;
Avirmed D
2
;
Erdenetsogt D
3
Author Information
1. Ach Medical University
2. National Cancer Center
3. Mongolian National University of Medical Sciences
- Publication Type:Journal Article
- Keywords:
Ovarian cancer;
immunohistochemistry;
HER2;
IHC;
ovary
- From:Mongolian Medical Sciences
2018;185(3):8-12
- CountryMongolia
- Language:Mongolian
-
Abstract:
Introduction :The occurrence of ovarian cancer had a trend of younger in recent years. Due to no obvious clinical symptoms in the early period, most ovarian cancer was found at later period. The main screening methods are transvaginal ultrasonography, serum CA-125 and so on. About 60-70% of ovarian cancer patients are already in phase III-IV or with abdominal metastasis when diagnosed. Therefore, the early diagnosis of ovarian cancer is still in the research, and there is no definite markers, which can be used in clinical.
Goal:To determine the immunohistology of ovarian tumor and perform immunohistochemical analysis
Materials and Methods:A total of epithelial ovarian cancer paraffin-embedded tissue blocks 30collected. The hematoxylin and eosin stained histopathology slides of each of the cases were reviewed to confirm the original diagnosis, and to assess the histological grade of the neoplasm. Our study was performed on 30 ovarian epithelial cancer tissues obtained at the time of first surgery. The staining procedure for HER2 overexpression was performed using a monoclonal antibody.
Results:Analysis histological subtypes of ovarian malignant cancer, 90% of ovarian epithelial ovarian cancer, 6.7% of sex cord-stromal and 3.3% of germ cell tumor. (G1) well differentiated, (G2) moderately differentiated, (G3) poorly differentiated were 23.3%, 40.0% and 36.7% respectively. There is statistically significant direct, medium correlation immunohistochemical examination, the HER2 protein over expression (r=0.38, р=0.022), and HER2 protein 3+ was higher in 66.7 percent were in poorly differentiated.
Conclusion:In our study ovarian cancer based on the morphological architecture of tissue stained by H&E histological subtypes of epithelial ovarian cancer (90%). By immunohistochemical 93.3% positive and 6.7% negative ovarian cancer in determine HER2 expression.
- Full text:2018-185(3)-8-12.pdf
